D L Hoffman

Summary

Country: USA

Publications

  1. ncbi Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives
    Mugdha Gore
    Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
    J Pain 7:892-900. 2006
  2. ncbi Human and economic burden of generalized anxiety disorder
    Deborah L Hoffman
    Independent Outcomes Research Consultant, New Haven, CT, USA
    Depress Anxiety 25:72-90. 2008
  3. ncbi The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12
    D L Hoffman
    Pfizer, Inc, New York, NY, USA
    Int J Clin Pract 62:115-26. 2008
  4. ncbi Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis
    Diane C Zelman
    California School of Professional Psychology Alliant International University, 1005 Atlantic Avenue, Alameda, CA 94501, USA
    Pain 106:35-42. 2003
  5. ncbi Therapy switching in patients receiving long-acting opioids
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445-7629, USA
    Ann Pharmacother 38:389-95. 2004
  6. ncbi Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep
    Mugdha Gore
    Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
    J Pain Symptom Manage 30:374-85. 2005

Collaborators

Detail Information

Publications6

  1. ncbi Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives
    Mugdha Gore
    Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
    J Pain 7:892-900. 2006
    ..Results also suggest suboptimal pain management and low levels of satisfaction with treatments...
  2. ncbi Human and economic burden of generalized anxiety disorder
    Deborah L Hoffman
    Independent Outcomes Research Consultant, New Haven, CT, USA
    Depress Anxiety 25:72-90. 2008
    ..Quality of care initiatives that have been implemented to increase recognition and improve treatment outcomes for persons with MDD should be extended to the effective management of GAD...
  3. ncbi The health status burden of people with fibromyalgia: a review of studies that assessed health status with the SF-36 or the SF-12
    D L Hoffman
    Pfizer, Inc, New York, NY, USA
    Int J Clin Pract 62:115-26. 2008
    ..The current review describes how the health status profile of people with fibromyalgia (FM) compares to that of people in the general population and patients with other health conditions...
  4. ncbi Development of a metric for a day of manageable pain control: derivation of pain severity cut-points for low back pain and osteoarthritis
    Diane C Zelman
    California School of Professional Psychology Alliant International University, 1005 Atlantic Avenue, Alameda, CA 94501, USA
    Pain 106:35-42. 2003
    ....
  5. ncbi Therapy switching in patients receiving long-acting opioids
    Ariel Berger
    Policy Analysis Inc, Brookline, MA 02445-7629, USA
    Ann Pharmacother 38:389-95. 2004
    ..CONCLUSIONS: Patients without cancer who receive CR oxycodone or transdermal fentanyl are less likely to switch therapy than those receiving CR morphine sulfate. Total healthcare charges are higher for patients who switch therapy...
  6. ncbi Pain severity in diabetic peripheral neuropathy is associated with patient functioning, symptom levels of anxiety and depression, and sleep
    Mugdha Gore
    Avalon Health Solutions, Inc, Philadelphia, Pennsylvania 19102, USA
    J Pain Symptom Manage 30:374-85. 2005
    ..01). Painful DPN is associated with decrements in many aspects of patients' lives: physical and emotional functioning, affective symptoms, and sleep problems. The negative impact is higher in patients with greater pain severity...